Update: Investigation of bioterrorism-related anthrax, 2001

MMWR Morb Mortal Wkly Rep. 2001 Nov 16;50(45):1008-10.

Abstract

This report updates the investigation of bioterrorism-related anthrax and the provision of antimicrobial prophylaxis to exposed persons and highlights CDC assistance to other countries investigating cases of bioterrorism-related anthrax. Since November 7, 2001, CDC and state and local public health agencies have identified no new cases of bioterrorism-related anthrax. As of November 14, a total of 22 cases of anthrax has met the CDC case definition; 10 were confirmed inhalational anthrax, and 12 (seven confirmed and five suspected) were cutaneous anthrax. Investigation of a case of inhalational anthrax in a hospital stock room worker aged 61 years in New York City (NYC) found no evidence of anthrax contamination at the work site or home; the source of exposure is unknown. Environmental clean-up of contaminated facilities continues, and surveillance for newcases of bioterrorism-related anthrax is ongoing in Delaware (DE), District of Columbia (DC), Florida (FL), Maryland (MD), New Jersey (NJ), NYC, Pennsylvania (PA), Virginia (VA), and other states.

MeSH terms

  • Anthrax* / epidemiology
  • Anthrax* / prevention & control
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Bacillus anthracis*
  • Bioterrorism*
  • Centers for Disease Control and Prevention, U.S.
  • Environmental Exposure*
  • Global Health
  • Humans
  • Occupational Exposure
  • Public Health Practice
  • Respiratory Tract Infections* / epidemiology
  • Respiratory Tract Infections* / prevention & control
  • Skin Diseases, Bacterial* / epidemiology
  • Skin Diseases, Bacterial* / prevention & control
  • Spores, Bacterial*
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents